Abstract
An 81-year-old woman presented with blurred vision in the left eye. Best corrected visual acuity was 20/100. Ophthalmologic examination in the left eye revealed tilted disc syndrome with exudative change at the margin of inferior staphyloma. The exudative change persisted despite monthly intravitreal ranibizumab injections for 5 months. Subsequently, two intravitreal aflibercept injections 1 month apart were substituted for the ranibizumab injections, resulting in successful resolution of the exudative change.
Copyright 2015, SLACK Incorporated.
MeSH terms
-
Aged, 80 and over
-
Angiogenesis Inhibitors / therapeutic use*
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Coloring Agents
-
Drug Substitution
-
Epiretinal Membrane / diagnosis
-
Epiretinal Membrane / drug therapy
-
Eye Abnormalities / diagnosis
-
Eye Abnormalities / drug therapy*
-
Female
-
Fluorescein Angiography
-
Humans
-
Indocyanine Green
-
Intravitreal Injections
-
Macular Edema / diagnosis
-
Macular Edema / drug therapy
-
Optic Disk / abnormalities*
-
Ranibizumab
-
Receptors, Vascular Endothelial Growth Factor / therapeutic use*
-
Recombinant Fusion Proteins / therapeutic use*
-
Retinal Detachment / diagnosis
-
Retinal Detachment / drug therapy
-
Retinal Diseases / diagnosis
-
Retinal Diseases / drug therapy*
-
Retinal Pigment Epithelium / drug effects
-
Retinal Pigment Epithelium / pathology
-
Subretinal Fluid / drug effects*
-
Tomography, Optical Coherence
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal, Humanized
-
Coloring Agents
-
Recombinant Fusion Proteins
-
VEGFA protein, human
-
Vascular Endothelial Growth Factor A
-
aflibercept
-
Receptors, Vascular Endothelial Growth Factor
-
Indocyanine Green
-
Ranibizumab